We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




Rapid Urine Test Detects Bacteria Causing Pneumonia

By LabMedica International staff writers
Posted on 28 Sep 2014
Print article
The BinaxNOW Streptococcus pneumoniae Antigen Card Test
The BinaxNOW Streptococcus pneumoniae Antigen Card Test (Photo courtesy of Abbott Rapid Diagnostics)
A simple, quick, first-of-a-kind urine test for detecting Streptococcus pneumoniae, one of the bacteria that are a leading cause of pneumonia, can also be used with cerebral spinal fluid (CSF) of patients with meningitis.

The aim of the test is to rule in S. pneumoniae as the probable cause of the pneumonia and the test results can enable a probable diagnosis to be made quicker so treatment can be started sooner with the appropriate antibiotics to combat the S. pneumoniae.

To do the test, a swab is dipped into a urine specimen, removed and inserted into a special test device. The test detects S. pneumoniae antigen in the urine of infected patients within 15 minutes. A positive result indicates that the patient most likely has pneumococcal pneumonia. Results should be confirmed with laboratory culture of the bacteria.

Conventional methods for diagnosing pneumonia, primarily using sputum or blood, are lengthy and require from two to three days up to several weeks. These conventional tests are often complex and the results are not always reliable. The new test, called Alere BinaxNOW Streptococcus pneumoniae Antigen Card (Binax, Inc.; Portland, ME, USA) is much quicker, more reliable and easier to use.

The Binax test was found to be 93% accurate in detecting S. pneumoniae when it was performed on urine samples from 373 patients known to have pneumococcal pneumonia. It was 78% accurate when performed on urine from 215 patients who had typical symptoms of pneumonia, but may not have had the disease. However, test results were not reliable in people who had been vaccinated for pneumonia within the past five days. The urine test’s sensitivity was 86% and specificity was 94%, while for CSF samples the sensitivity was 97% and specificity 99%.

It is often very difficult to distinguish between a respiratory infection that is caused by a virus and one which is caused by a bacterium and this is critical distinction because a viral infection will not respond to the commonly used antibiotics whereas a bacterial infection usually will. The Binax test can help in detecting the bacterium S. pneumoniae but it does not detect other bacteria nor does it detect viruses capable of causing pneumonia.

Related Links:

Binax, Inc. 


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
New
Gold Member
Magnetic Bead Separation Modules
MAG and HEATMAG
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get complete access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: A blood test could predict lung cancer risk more accurately and reduce the number of required scans (Photo courtesy of 123RF)

Blood Test Accurately Predicts Lung Cancer Risk and Reduces Need for Scans

Lung cancer is extremely hard to detect early due to the limitations of current screening technologies, which are costly, sometimes inaccurate, and less commonly endorsed by healthcare professionals compared... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Pathology

view channel
Image: The new method could reduce undiagnosed cancer cases in less-developed regions (Photo courtesy of 123RF)

New Method Offers Sustainable Approach to Universal Metabolic Cancer Diagnosis

Globally, more than one billion people suffer from a high rate of missed disease diagnosis, highlighting the urgent need for more precise and affordable diagnostic tools. Such tools are especially crucial... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.